Vanguard Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $57M | Sell |
|
|||||
|
2025
Q2 | $49.2M | Sell |
|
|||||
|
2025
Q1 | $94.6M | Buy |
|
|||||
|
2024
Q4 | $145M | Buy |
|
|||||
|
2024
Q3 | $282M | Buy |
|
|||||
|
2024
Q2 | $246M | Buy |
|
|||||
|
2024
Q1 | $214M | Buy |
|
|||||
|
2023
Q4 | $191M | Buy |
|
|||||
|
2023
Q3 | $147M | Buy |
|
|||||
|
2023
Q2 | $212M | Sell |
|
|||||
|
2023
Q1 | $216M | Sell |
|
|||||
|
2022
Q4 | $135M | Buy |
|
|||||
|
2022
Q3 | $174M | Buy |
|
|||||
|
2022
Q2 | $164M | Buy |
|
|||||
|
2022
Q1 | $226M | Sell |
|
|||||
|
2021
Q4 | $253M | Buy |
|
|||||
|
2021
Q3 | $292M | Buy |
|
|||||
|
2021
Q2 | $274M | Buy |
|
|||||
|
2021
Q1 | $263M | Buy |
|
|||||
|
2020
Q4 | $164M | Buy |
|
|||||
|
2020
Q3 | $104M | Sell |
|
|||||
|
2020
Q2 | $93.5M | Sell |
|
|||||
|
2020
Q1 | $120M | Buy |
|
|||||
|
2019
Q4 | $227M | Sell |
|
|||||
|
2019
Q3 | $248M | Buy |
|
|||||
|
2019
Q2 | $231M | Sell |
|
|||||
|
2019
Q1 | $283M | Sell |
|
|||||
|
2018
Q4 | $267M | Buy |
|
|||||
|
2018
Q3 | $398M | Buy |
|
|||||
|
2018
Q2 | $310M | Buy |
|
|||||
|
2018
Q1 | $230M | Buy |
|
|||||
|
2017
Q4 | $248M | Buy |
|
|||||
|
2017
Q3 | $229M | Buy |
|
|||||
|
2017
Q2 | $163M | Buy |
|
|||||
|
2017
Q1 | $120M | Buy |
|
|||||
|
2016
Q4 | $89.2M | Buy |
|
|||||
|
2016
Q3 | $107M | Sell |
|
|||||
|
2016
Q2 | $159M | Buy |
|
|||||
|
2016
Q1 | $190M | Buy |
|
|||||
|
2015
Q4 | $209M | Buy |
|
|||||
|
2015
Q3 | $175M | Sell |
|
|||||
|
2015
Q2 | $159M | Sell |
|
|||||
|
2015
Q1 | $168M | Sell |
|
|||||
|
2014
Q4 | $162M | Sell |
|
|||||
|
2014
Q3 | $185M | Sell |
|
|||||
|
2014
Q2 | $197M | Buy |
|
|||||
|
2014
Q1 | $167M | Sell |
|
|||||
|
2013
Q4 | $102M | Buy |
|
|||||
|
2013
Q3 | $114M | Buy |
|
|||||
|
2013
Q2 | $118M | Buy |
|